,outcome,arm 1,arm 2
0,intervention,,docetaxel
0,efficacy in time to disease progression ( TTP ),NR,"11.5 months, 30 %, 4.2 months"
0,"efficacy in time to disease progression ( TTP ), total study group","14.5, 42 %, 6.1","14.5, 42 %, 6.1"
